Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic

Written By Guest User

Click the link below to view this Short Report published in the British Journal of Haematology by NHP clinicians and researchers.

Guest User
Previous

New guidance for clinicians on COVID-19 in patients with haemoglobinopathies and inherited rare anaemias.
Next

COVID-19 and Haemoglobinopathies: National Data Collection - Presentation to All-Party Parliamentary Group on Sickle Cell and Thalassaemia